Canada markets closed

Little Green Pharma Ltd (LGP.XA)

Cboe AU - Cboe AU Real Time Price. Currency in AUD
Add to watchlist
0.0990-0.0035 (-3.41%)
As of 11:15AM AEST. Market open.
Currency in AUD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3-37.88%
S&P500 52-Week Change 324.96%
52 Week High 30.2050
52 Week Low 30.0990
50-Day Moving Average 30.1238
200-Day Moving Average 30.1380

Share Statistics

Avg Vol (3 month) 371.42k
Avg Vol (10 day) 387.97k
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 8161.72M
% Held by Insiders 132.25%
% Held by Institutions 111.04%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -31.81%
Operating Margin (ttm)-44.88%

Management Effectiveness

Return on Assets (ttm)-5.20%
Return on Equity (ttm)-10.22%

Income Statement

Revenue (ttm)25.63M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)22.30%
Gross Profit (ttm)N/A
EBITDA -5.02M
Net Income Avi to Common (ttm)-8.15M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.97M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)5.14M
Total Debt/Equity (mrq)6.66%
Current Ratio (mrq)3.34
Book Value Per Share (mrq)0.26

Cash Flow Statement

Operating Cash Flow (ttm)66.79k
Levered Free Cash Flow (ttm)245.6k